Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.28 - $1.16 $55,631 - $230,473
-198,684 Reduced 24.15%
624,000 $209 Million
Q1 2024

May 13, 2024

BUY
$1.06 - $1.67 $187,285 - $295,062
176,684 Added 27.35%
822,684 $954 Million
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $813,960 - $1.16 Million
646,000 New
646,000 $1.09 Billion

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $13B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Polymer Capital Management (Hk) LTD Portfolio

Follow Polymer Capital Management (Hk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polymer Capital Management (Hk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Polymer Capital Management (Hk) LTD with notifications on news.